Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.

A novel reduction-responsive drug delivery system was successfully constructed with mesoporous silica nanoparticle (MSN) core as a drug carrier and poly(acrylic acid) (PAA) shell crosslinked by disulfide linkages as a drug release switcher. To keep the pore structure of MSN intact, PAA was covalently attached to the exterior surface of MSN before removing structure-template via radical polymerization. After removing structure-template and loading doxorubicin (DOX), the PAA shell was crosslinked by cystamine dihydrochloride through amidation reaction. The loading content and the entrapment efficiency of DOX could reach up to 40.2% and 80.4%, respectively. Because that the dissociation of disulfide linkage is reduction-responsive, the release behavior of DOX could be controlled by varying the concentration of reductant, and the release rate was 49.4% after 24h with the existence of 2 mM glutathione (simulated environment of cancer cells), about three times higher than that of without glutathione (corresponding to normal human cells), which was only 16.9%. The in vitro cell assays demonstrated that the disulfide linkages crosslinked MSN-PAA (MSN-PAA-crosslinked) was highly biocompatible and suitable to use as drug carrier, and the DOX loaded MSN-PAA-crosslinked showed remarkable cytotoxicity to HeLa cells (human cancer cells), and relatively lower cytotoxicity to 293 cells (human normal cells). These results imply that the MSN-PAA-crosslinked is a promising platform to construct reduction-responsive controlled drug delivery system for cancer therapy.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  V. S. Lin,et al.  Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. , 2009, Journal of the American Chemical Society.

[3]  K. Nguyen,et al.  Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. , 2012, International journal of pharmaceutics.

[4]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[5]  Jianlin Shi,et al.  Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility , 2011 .

[6]  Xin Li,et al.  Fabrication of smart nanocontainers with a mesoporous core and a pH-responsive shell for controlled uptake and release , 2009 .

[7]  E. Gil,et al.  Stimuli-reponsive polymers and their bioconjugates , 2004 .

[8]  Wenqiang Huang,et al.  Synthesis of Narrow or Monodisperse Poly(divinylbenzene) Microspheres by Distillation−Precipitation Polymerization , 2004 .

[9]  Anil K Patri,et al.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. , 2005, Advanced drug delivery reviews.

[10]  M. Vallet‐Regí,et al.  Revisiting silica based ordered mesoporous materials: medical applications , 2006 .

[11]  Katie R. Hurley,et al.  Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles. , 2012, The journal of physical chemistry letters.

[12]  J. Eiseman,et al.  N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities. , 2005, Bioconjugate chemistry.

[13]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[14]  Victor S-Y Lin,et al.  Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system. , 2011, Chemical communications.

[15]  S. Simões,et al.  Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[17]  M. Vallet‐Regí,et al.  Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .

[18]  É. Duguet,et al.  Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .

[19]  Zhiyuan Zhong,et al.  Polymersomes Spanning from Nano- to Microscales: Advanced Vehicles for Controlled Drug Delivery and Robust Vesicles for Virus and Cell Mimicking , 2011 .

[20]  W. Hennink,et al.  Reduction-sensitive polymers and bioconjugates for biomedical applications. , 2009, Biomaterials.

[21]  K. Kataoka,et al.  Environment-Sensitive Stabilization of Core−Shell Structured Polyion Complex Micelle by Reversible Cross-Linking of the Core through Disulfide Bond , 1999 .

[22]  I. Ojima.  Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads. , 2008, Accounts of chemical research.

[23]  F. Caruso,et al.  Noncovalent liposome linkage and miniaturization of capsosomes for drug delivery. , 2010, Biomacromolecules.

[24]  Juan L. Vivero-Escoto,et al.  Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. , 2009, Chemical communications.

[25]  Brian G. Trewyn,et al.  Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications , 2007 .

[26]  Dong Yang,et al.  Preparation of copolymer paclitaxel covalently linked via a disulfide bond and its application on controlled drug delivery. , 2012, The journal of physical chemistry. B.

[27]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[28]  D. Schmaljohann.  Thermo- and pH-responsive polymers in drug delivery. , 2006, Advanced drug delivery reviews.

[29]  T. Taguchi,et al.  Photo-Switched Storage and Release of Guest Molecules in the Pore Void of Coumarin-Modified MCM-41 , 2003 .

[30]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.

[31]  A. Stein,et al.  Morphology Control of Carbon, Silica, and Carbon/Silica Nanocomposites : From 3D Ordered Macro-/Mesoporous Monoliths to Shaped Mesoporous Particles , 2008 .

[32]  R. Xing,et al.  Biofunctional mesoporous silica nanoparticles for magnetically oriented target and pH-responsive controlled release of ibuprofen , 2012 .

[33]  L. J. Mueller,et al.  pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. , 2010, Journal of the American Chemical Society.